Top Markets
Coin of the day
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Pozycja w akcjach #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Cena akcji
$2.23
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$95.23M
Zmiana (1 dzień)
1.14%
Zmiana (1 rok)
63.60%
Kraj
US
Handel Acrivon Therapeutics, Inc. Common Stock (ACRV)

Kategoria

Liczba akcji w obrocie dla Acrivon Therapeutics, Inc. Common Stock (ACRV)
Liczba akcji w obrocie na dzień August 2026: 0
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Acrivon Therapeutics, Inc. Common Stock, aktualna liczba akcji w obrocie to 0. Na koniec August 2026 firma posiadała 0 akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Acrivon Therapeutics, Inc. Common Stock (ACRV) od 2026 do 2026
Akcje w obrocie na koniec każdego roku
Rok Akcje w obrocie Zmień
Za mało danych dla podanych dat.
Akcje w obrocie dla podobnych firm lub konkurentów
Firma Akcje w obrocie Różnica Kraj
253.90M -
US
62.19M -
NL
396.00M -
US
478.91M -
AU
- -
CH